Hunan Jiudian Pharmaceutical Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd., commonly referred to as Jiudian Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, primarily focusing on innovative drug formulations and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in China, Jiudian Pharmaceutical is renowned for its commitment to research and development, which has led to the successful launch of several unique products. The company’s core offerings include a diverse range of prescription medications and over-the-counter solutions, distinguished by their efficacy and safety profiles. Recognised for its robust market position, Hunan Jiudian Pharmaceutical has achieved notable milestones, including certifications from international regulatory bodies, underscoring its dedication to quality and compliance in the pharmaceutical sector.
DitchCarbon Score
How does Hunan Jiudian Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hunan Jiudian Pharmaceutical Co., Ltd.'s score of 37 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hunan Jiudian Pharmaceutical Co., Ltd.'s reported carbon emissions
Hunan Jiudian Pharmaceutical Co., Ltd., headquartered in China, has reported its carbon emissions data for the years 2021 to 2024. In 2023, the company emitted approximately 7,139,500 kg CO2e from Scope 1 emissions, 12,268,800 kg CO2e from Scope 2 emissions, and 1,076,000 kg CO2e from Scope 3 emissions. This represents a notable increase in emissions compared to 2022, where emissions were about 5,508,300 kg CO2e (Scope 1), 8,957,800 kg CO2e (Scope 2), and 553,100 kg CO2e (Scope 3). In 2024, Hunan Jiudian Pharmaceutical aims to reduce its emissions to approximately 4,901,900 kg CO2e (Scope 1), 10,472,900 kg CO2e (Scope 2), and 770,100 kg CO2e (Scope 3). This indicates a commitment to lowering its carbon footprint, although specific reduction targets or initiatives have not been disclosed. Overall, while the company has shown fluctuations in its emissions, it is actively working towards reducing its carbon impact in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 5,710,200 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 8,439,400 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 765,700 | 000,000 | 0,000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hunan Jiudian Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
